Residual Cancer Burden (RCB) is part of the pathology report and has been proven to be a good prognosticator (predictor) of disease recurrence and survival after neoadjuvant (pre-) chemo. This disease recurrence and survival is called Event-Free Survival.
Event-free survival (EFS) is a measurement of how long a cancer patient remains free of certain complications or events after treatment. These events may include the return of the cancer, the onset of certain symptoms, or the progression of disease that would prevent surgery.
This calculator was developed to have a standardized way of predicting the RCB.
My results are as follows:
Due to my HR+/HER2+ status, this puts my 5 year EFS at 76% and 10 year EFS at 64%.
No comments:
Post a Comment